[1]Locationinpatent:experimentalpartXu,Lin;Muller,MarcR.;Yu,Xiong;Zhu,Bao-Quan[SyntheticCommunications,2009,vol.39,#9,p.1611-1625]
[2]Tamura,Keiji;Kumagai,Naoya;Shibasaki,Masakatsu[JournalofOrganicChemistry,2014,vol.79,#7,p.3272-3278]
[3]Tsuruoka,Akihiko;Kaku,Yumiko;Kakinuma,Hiroyuki;Tsukada,Itaru;Yanagisawa,Manabu;Nara,Kazumasa;Naito,Toshihiko[ChemicalandPharmaceuticalBulletin,1998,vol.46,#4,p.623-630]
[4]CurrentPatentAssignee:METROCHEMAPIPRIVATE-WO2021/245590,2021,A1Locationinpatent:Page/Pagecolumn22-23
[5]CurrentPatentAssignee:METROCHEMAPIPRIVATE-WO2021/245590,2021,A1Locationinpatent:Page/Pagecolumn22-23
[1]Tsuruoka,Akihiko;Kaku,Yumiko;Kakinuma,Hiroyuki;Tsukada,Itaru;Yanagisawa,Manabu;Nara,Kazumasa;Naito,Toshihiko[ChemicalandPharmaceuticalBulletin,1998,vol.46,#4,p.623-630]
[1]Tsuruoka,Akihiko;Kaku,Yumiko;Kakinuma,Hiroyuki;Tsukada,Itaru;Yanagisawa,Manabu;Nara,Kazumasa;Naito,Toshihiko[ChemicalandPharmaceuticalBulletin,1998,vol.46,#4,p.623-630]
182760-06-1
[1]Ohwada,Jun;Murasaki,Chikako;Yamazaki,Toshikazu;Ichihara,Shigeyasu;Umeda,Isao;Shimma,Nobuo[BioorganicandMedicinalChemistryLetters,2002,vol.12,#19,p.2775-2780]
241479-84-5
[1]Ohwada,Jun;Murasaki,Chikako;Yamazaki,Toshikazu;Ichihara,Shigeyasu;Umeda,Isao;Shimma,Nobuo[BioorganicandMedicinalChemistryLetters,2002,vol.12,#19,p.2775-2780]
Title: Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Journal: Journal of medicinal chemistry 20140508
Title: Hybrids of ravuconazole: synthesis and biological evaluation.
Journal: European journal of medicinal chemistry 20120801
Title: Newer antifungal agents.
Journal: Expert review of anti-infective therapy 20110301
Title: In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Journal: Antimicrobial agents and chemotherapy 20101101
Title: [Recent advances in the study of new antifungal lead compounds].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20100801
Title: Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Journal: Antimicrobial agents and chemotherapy 20100701
Title: Onychomycosis.
Journal: Clinics in dermatology 20100304
Title: Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Journal: Current opinion in investigational drugs (London, England : 2000) 20100201
Title: In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Journal: Antimicrobial agents and chemotherapy 20090801
Title: Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Journal: Antimicrobial agents and chemotherapy 20090401
Title: Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Journal: Journal of clinical microbiology 20080901
Title: In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Journal: Antimicrobial agents and chemotherapy 20080601
Title: Discovery of novel indazole-linked triazoles as antifungal agents.
Journal: Bioorganic & medicinal chemistry letters 20070615
Title: Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Journal: Antimicrobial agents and chemotherapy 20061201
Title: Multi-azole resistance in Aspergillus fumigatus.
Journal: International journal of antimicrobial agents 20061101
Title: Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.
Journal: The Journal of infectious diseases 20061001
Title: Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Journal: Expert opinion on investigational drugs 20060601
Title: In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Journal: Mycoses 20060501
Title: The effect of ravuconazole on the pharmacokinetics of nelfinavir in healthy male volunteers.
Journal: Journal of clinical pharmacology 20060201
Title: In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.
Journal: Antimicrobial agents and chemotherapy 20051201
Title: Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.
Journal: The Journal of antimicrobial chemotherapy 20051101
Title: Advances in antifungal therapy.
Journal: The Pediatric infectious disease journal 20051001
Title: Antifungal agents in children.
Journal: Pediatric clinics of North America 20050601
Title: In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
Journal: Medical mycology 20050501
Title: In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Journal: Medical mycology 20050301
Title: Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
Journal: Journal of clinical microbiology 20041001
Title: Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Journal: Mycoses 20040801
Title: In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Journal: Diagnostic microbiology and infectious disease 20040201
Title: In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Journal: Diagnostic microbiology and infectious disease 20040101
Title: In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20031201
Title: Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties.
Journal: Bioorganic & medicinal chemistry letters 20031103
Title: Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Journal: Journal of clinical microbiology 20030801
Title: New antifungal agents.
Journal: Dermatologic clinics 20030701
Title: Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.
Journal: The Journal of infectious diseases 20030615
Title: In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.
Journal: Antimicrobial agents and chemotherapy 20030401
Title: In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease.
Journal: International journal of antimicrobial agents 20030101
Title: [Present status and future prospects of azole antifungal agents in Japan].
Journal: The Japanese journal of antibiotics 20021201
Title: Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Journal: Current opinion in infectious diseases 20021201
Title: Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
Journal: Bioorganic & medicinal chemistry letters 20021007
Title: In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
Journal: The Journal of antimicrobial chemotherapy 20020701
Title: In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Journal: Antimicrobial agents and chemotherapy 20020601
Title: Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
Journal: Journal of clinical microbiology 20020501
Title: Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
Journal: Antimicrobial agents and chemotherapy 20020401
Title: Ravuconazole Eisai/Bristol-Myers Squibb.
Journal: Current opinion in investigational drugs (London, England : 2000) 20020401
Title: Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Journal: Antimicrobial agents and chemotherapy 20020301
Title: Penetration of ravuconazole, a new triazole antifungal, into rat tissues.
Journal: Chemotherapy 20020301
Title: Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis.
Journal: The Journal of antimicrobial chemotherapy 20020201
Title: Antifungals: what's in the pipeline.
Journal: Current opinion in microbiology 20011001
Title: In vitro activities of four novel triazoles against Scedosporium spp.
Journal: Antimicrobial agents and chemotherapy 20010701
Title: Effect of ravuconazole, a new triazole antifungal, in a rat intraabdominal abscess model.
Journal: Chemotherapy 20010101
Title: Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis.
Journal: Antimicrobial agents and chemotherapy 20001201
Title: In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B.
Journal: Antimicrobial agents and chemotherapy 20000201
Title: In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Journal: Diagnostic microbiology and infectious disease 19991001
Title: In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Journal: Antimicrobial agents and chemotherapy 19981201
Title: New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Journal: Journal of medicinal chemistry 19980521
Title: New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Journal: Journal of medicinal chemistry 19980521
Title: In vitro activity of a new oral triazole, BMS-207147 (ER-30346).
Journal: Antimicrobial agents and chemotherapy 19980201
Title: In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Journal: Antimicrobial agents and chemotherapy 19961001
Title: Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Journal: Antimicrobial agents and chemotherapy 19961001
Title: Hata K, et al. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.Antimicrob Agents Chemother. 1996 Oct;40(10):2237-42.
Title: Fung-Tomc JC, et al. In vitro activity of a new oral triazole, BMS-207147 (ER-30346)Antimicrob Agents Chemother. 1998 Feb;42(2):313-8.
Title: Hata K, et al. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.Antimicrob Agents Chemother. 1996 Oct;40(10):2243-7.
